Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes: Gusto IV-ACS

被引：6

作者：

Cohen, M ^{[1
]}

机构：

[1] Med Coll Penn & Hahnemann Univ, Sch Med, Div Cardiol, Philadelphia, PA 19102 USA

来源：

LANCET | 2001年 / 357卷 / 9272期

关键词：

D O I：

10.1016/S0140-6736(00)05088-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1899 / 1900

页数：2

共 10 条

[1] The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making [J].

Antman, EM ;

Cohen, M ;

Bernink, PJLM ;

McCabe, CH ;

Horacek, T ;

Papuchis, G ;

Mautner, B ;

Corbalan, R ;

Radley, D ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07) :835-842

[2] Management of acute coronary syndromes:: acute coronary syndromes without persistent ST segment elevation -: Recommendations of the Task Force of the European Society of Cardiology [J].

Bertrand, ME ;

Simoons, ML ;

Fox, KAA ;

Wallentin, LC ;

Hamm, CW ;

McFadden, E ;

De Feyter, PJ ;

Specchia, G ;

Ruzyllo, W .

EUROPEAN HEART JOURNAL, 2000, 21 (17) :1406-1432

[3] ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) [J].

Braunwald, E ;

Antman, EM ;

Beasley, JW ;

Califf, RM ;

Cheitlin, MD ;

Hochman, JS ;

Jones, RH ;

Kereiakes, D ;

Kupersmith, J ;

Levin, TN ;

Pepine, CJ ;

Schaeffer, JW ;

Smith, EE ;

Steward, DE ;

Theroux, P ;

Gibbons, RJ ;

Alpert, JS ;

Eagle, KA ;

Faxon, DP ;

Fuster, V ;

Gardner, TJ ;

Gregoratos, G ;

Russell, RO ;

Smith, SC .

CIRCULATION, 2000, 102 (10) :1193-1209

[4]

Cohen M, 1999, CIRCULATION, V100, P641

[5] Angiographic findings in patients with refractory unstable angina according to troponin T status [J].

Heeschen, C ;

van den Brand, MJ ;

Hamm, CW ;

Simoons, ML .

CIRCULATION, 1999, 100 (14) :1509-1514

[6] Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention [J].

Kereiakes, DJ ;

Broderick, TM ;

Roth, EM ;

Whang, D ;

Shimshak, T ;

Runyon, JP ;

Hattemer, C ;

Schneider, J ;

Lacock, P ;

Mueller, M ;

Abbottsmith, CW .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (04) :391-395

[7]

Quinn MJ, 2001, J PHARMACOL EXP THER, V297, P496

[8] Platelet glycoprotein IIb/IIIa antagonists - What are the relevant issues concerning their pharmacology and clinical use? [J].

Scarborough, RM ;

Kleiman, NS ;

Phillips, DR .

CIRCULATION, 1999, 100 (04) :437-444

[9] RANDOMIZED TRIAL OF A GPIIB/IIIA PLATELET RECEPTOR BLOCKER IN REFRACTORY UNSTABLE ANGINA [J].

SIMOONS, ML ;

DEBEER, MJ ;

VANDENBRAND, MJBM ;

VANMILTENBURG, AJM ;

HOORNTJE, JCA ;

HEYNDRICKX, GR ;

VANDERWIEKEN, LR ;

DEBONO, D ;

RUTSCH, W ;

SCHAIBLE, TF ;

WEISMAN, HF ;

KLOOTWIJK, P ;

NIJSSEN, KM ;

STIBBE, J ;

DEFEYTER, PJ .

CIRCULATION, 1994, 89 (02) :596-603

[10] Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients - Angiographic results from the CAPTURE trial [J].

van den Brand, M ;

Laarman, GJ ;

Steg, PG ;

De Scheerder, I ;

Heyndrickx, G ;

Beatt, K ;

Kootstra, J ;

Simoons, ML .

EUROPEAN HEART JOURNAL, 1999, 20 (21) :1572-1578

← 1 →